IMAX China Holding Inc (1970)
Hong Kong Stock Exchange · Hong Kong · prices in HKD · close of 27 Oct 2026
Key indicators
| Last close | HKD 7.830 |
|---|---|
| 52-week range | 7.190 – 9.100 |
| Return, 1 month / 3 months | −7.6% / −6.5% |
| Return, 1 year / 3 years | +1.6% / +6.7% |
| Trend | Below its 200-day average |
| RSI (14) | 30 |
| Volatility (1 year) | 28.1% |
| Worst drawdown (1 year) | -19.5% |
| Average daily value traded | 1.56M HKD |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
IMAX China Holding brings large-format cinema to audiences across Greater China. The company installs and maintains IMAX projection and sound systems in theatres operated by exhibition partners, and it supplies the associated technology and services that let those venues show films in the IMAX format. Its customers are cinema operators and film studios, and its business centres on the Chinese mainland, Hong Kong and Taiwan. The company is based in Hong Kong and works closely with its parent, IMAX Corporation.
IMAX China Holding Inc trades under the code 1970 on the Hong Kong Stock Exchange in Hong Kong, with its price quoted in Hong Kong dollars (HKD). Our dividend records, which start in 2019, show payments in 5 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
IMAX China Holding Inc (1970) trades on the Hong Kong Stock Exchange in Hong Kong. It last closed at HKD 7.830 on 27 October 2026.
Its price-based Market X-Ray is 76 out of 100 (a strong price profile), ranking 172 of 2,619 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 1.6% and over the last three months it fell 6.5%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Hong Kong Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 78 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | -4.2% | ||
| From 52-week high | -13.1% | ||
| Momentum | 67 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -6.5% | ||
| 6-month return | 3.0% | ||
| 12-month return, skipping the last month | 9.9% | ||
| Stability (higher is calmer) | 91 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 28.1% | ||
| Worst drawdown, 1 year (smaller is calmer) | -19.5% | ||
| Liquidity | 64 · Fair | Moderate trading activity. | |
| Average daily value traded | 1.56M HKD | ||
| Zero-volume days | 15.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 2 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | −7.9% |
|---|---|
| 1 month | −7.6% |
| 3 months | −6.5% |
| 6 months | +3.0% |
| 1 year | +1.6% |
| 3 years | +6.7% |
| 5 years | −31.3% |
Signals
| 50-day / 200-day average | 8.470 / 8.171 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.254 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 9 Jun 2023 | HKD 0.1170 |
| 9 Aug 2022 | HKD 0.0080 |
| 27 Jun 2022 | HKD 0.2100 |
| 11 Aug 2021 | HKD 0.2170 |
| 13 May 2021 | HKD 0.1550 |
| 12 Aug 2020 | HKD 0.1550 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Hong Kong Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.